Terry Pirovolakis received regulatory approval for the clinical treatment this past December – first, in hopes of saving the life of his six-year-old son, and now to help all affected by the rare disease Terry Pirovolakis received regulatory approval for the clinical treatment this past December – first, in hopes of saving the life of his six-year-old son, and now to help all affected by the rare disease